MS treatment trends before, during, and after the COVID-19 pandemic: insights from the German MS Register
There were no delays in DMT initiation or resumption during the pandemic with a notable increase in heDMT and BCD use, reflecting growing confidence in these treatment options.
Authors
- Agni Konitsioti (ORCID: https://orcid.org/0000-0002-7296-4349)
- Paulus Stefan Rommer (ORCID: https://orcid.org/0000-0001-5209-6647)
- Sarah Laurent (ORCID: https://orcid.org/0000-0001-8997-3017)
- Alexander Stahmann (ORCID: https://orcid.org/0000-0001-5308-105X)
- David Ellenberger (ORCID: https://orcid.org/0000-0002-2274-5025)
- Clemens Warnke (ORCID: https://orcid.org/0000-0002-3510-9255)
- Judith Haas
Institutions
- Université Libre de Bruxelles (BE)
- German Institute of Development and Sustainability (DE)
- Philipps University of Marburg (DE)
- University Hospital Cologne (DE)
- Centre Hospitalier Universitaire de Saint-Pierre (BE)
- Deutsche Multiple Sklerose Gesellschaft (DE)
- University of Rostock (DE)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Journal of Neurology
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1007/s00415-025-13010-6
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Universitätsklinikum Köln